Congenital Hypothyroidism: Long-Term Experience with Early and High Levothyroxine Dosage

Marie Uyttendaele1, Sophie Lambert, Sylvie Tenoutasse

  • 1Pediatric Endocrinology Unit, Hx00F4;pital Universitaire des Enfants Reine Fabiola, Universitx00E9; Libre de Bruxelles (ULB), Brussels, Belgium.

Insights

Congenital hypothyroidism (CH) management has improved with neonatal screening. Early levothyroxine treatment ensures normal growth and development in affected children.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Genetics

Background:

  • Congenital hypothyroidism (CH) is a common endocrine disorder in newborns.
  • Systemic neonatal screening has become standard for early CH detection.
  • Understanding CH management and outcomes is crucial for pediatric endocrinology.

Purpose of the Study:

  • To evaluate the management and outcomes of CH patients since implementing neonatal screening.
  • To analyze the impact of early diagnosis and treatment on CH patient growth and development.

Main Methods:

  • Retrospective review of 139 CH patients' records (1978-2014).
  • Analysis of biochemical and imaging data at diagnosis, treatment initiation, and growth parameters.
  • Comparison of outcomes between different CH etiologies (thyroid dysgenesis vs. gland in situ).

Main Results:

  • Thyroid dysgenesis was the most common cause of CH (111/139 patients).
  • Levothyroxine treatment initiated at a median of 11 days (mean dose 11.4 µg/kg/day).
  • Early treatment correlated with earlier TSH normalization and normal growth trajectories compared to reference populations.

Conclusions:

  • Ectopic thyroid tissue is the most frequent cause of CH.
  • Early levothyroxine therapy (mean dose 11.4 µg/kg/day) leads to normalized TSH levels (median 3.07 mU/l at 1 month) and normal growth in children with CH.
Abstract

Related Concept Videos

Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
6.5K
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
8.9K
The Thyroid Gland01:23

The Thyroid Gland

The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
8.6K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
726
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.2K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.5K